Netherlands vs Switzerland: Estimated antiretroviral therapy coverage among people living with HIV
Netherlands
89.0%
in 2024
Switzerland
89.0%
in 2024
Netherlands rank
22nd
Switzerland rank
22nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Netherlands
- Switzerland
How they compare
Netherlands currently reports 89.0% against 89.0% in Switzerland, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Netherlands ahead.
Netherlands ranks 22nd and Switzerland ranks 22nd of 143 countries.
Across the 3 decades both report, Netherlands averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Netherlands | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.5% | 52.9% | 0.6% | Netherlands |
| 2010s | 77.1% | 78.9% | 1.8% | Switzerland |
| 2020s | 87.8% | 89.0% | 1.2% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Netherlands or Switzerland?
- Netherlands, at 89.0% against 89.0% in Switzerland as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Netherlands and Switzerland?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Switzerland?
- 25 years are reported by both, from 2000 to 2024.
- How do Netherlands and Switzerland rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Netherlands ranks 22nd and Switzerland ranks 22nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.